Insulin Glulisine and Lithium Interaction

Drug interaction information between Insulin Glulisine and Lithium.

Insulin Glulisine and Lithium have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Insulin Glulisine and Lithium. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Insulin Glulisine

Rapid-Acting Insulin

Drug B

Lithium

Mood Stabilizer

How They Interact

Lithium can make blood sugar levels unpredictable by either helping or blocking the way insulin works in the body.

FDA Label Information

Drugs that May Increase or Decrease the Blood Glucose Lowering Effect of APIDRA Drugs: Alcohol, beta-blockers, clonidine, and lithium salts.

Insulin Glulisine Also Interacts With

View all Insulin Glulisine interactions →

Frequently Asked Questions

What SPL severity band is on file for Insulin Glulisine + Lithium?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Lithium has 90 labeled pairs on file vs Insulin Glulisine's 9. In the minor band specifically: Insulin Glulisine has 6 (also Albuterol, Clonidine, Epinephrine, Glucagon); Lithium has 65 (also Aripiprazole, Asenapine, Canagliflozin, Candesartan).

What mechanism field is on file for Insulin Glulisine and Lithium?

Lithium can make blood sugar levels unpredictable by either helping or blocking the way insulin works in the body.

Lithium carries more major-labeled pairs than Insulin Glulisine

SPL source-record counts only. This page's band is minor · classes on file: Insulin Glulisine (Rapid-Acting Insulin); Lithium (Mood Stabilizer).

Lithium has 2 major-labeled pairs vs Insulin Glulisine's 0. This page itself is in the minor band, not the major band.

Insulin Glulisine

0 major · 3 moderate · 6 minor · 9 total

Lithium

2 major · 23 moderate · 65 minor · 90 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.